Documents & Downloads

BbGL-2

Lipid

BbGL-2 is a glycosylated diacyl glycerol that serves as an antigenic compound. Its primary mechanism involves targeting lipid components, making it a promising candidate for vaccine development against Lyme disease. BbGL-2's biological activity includes the potential to elicit an immune response, facilitating research into novel vaccination strategies and understanding the pathogenesis of Lyme disease.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	780771-24-6
Applications	Lipid
Formula	C₄₃H₈₀O₁₀
Molecular Weight	757.09
SMILES	CCCCCCCC/C=C\CCCCCCCC(OC[C@@H](OC(CCCCCCCCCCCCCCC)=O)CO[C@H]1O[C@@H]([C@@H]([C@@H]([C@H]1O)O)O)CO)=O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.